V025-1160 Screening compound: 1-{5-BENZYL-4-OXO-4H,5H,6H,7H,8H-PYRAZOLO[1,5-A][1,4]DIAZEPINE-2-CARBONYL}-N-[2-(DIMETHYLAMINO)ETHYL]PIPERIDINE-4-CARBOXAMIDE

V025-1160 Screening compound: 1-{5-BENZYL-4-OXO-4H,5H,6H,7H,8H-PYRAZOLO[1,5-A][1,4]DIAZEPINE-2-CARBONYL}-N-[2-(DIMETHYLAMINO)ETHYL]PIPERIDINE-4-CARBOXAMIDE
V025-1160 Screening compound: 1-{5-BENZYL-4-OXO-4H,5H,6H,7H,8H-PYRAZOLO[1,5-A][1,4]DIAZEPINE-2-CARBONYL}-N-[2-(DIMETHYLAMINO)ETHYL]PIPERIDINE-4-CARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound V025-1160
1-{5-BENZYL-4-OXO-4H,5H,6H,7H,8H-PYRAZOLO[1,5-A][1,4]DIAZEPINE-2-CARBONYL}-N-[2-(DIMETHYLAMINO)ETHYL]PIPERIDINE-4-CARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V025-1160

Molecular Formula

C25H34N6O3 (C25 H34 N6 O3)

Compound Name

1-{5-BENZYL-4-OXO-4H,5H,6H,7H,8H-PYRAZOLO[1,5-A][1,4]DIAZEPINE-2-CARBONYL}-N-[2-(DIMETHYLAMINO)ETHYL]PIPERIDINE-4-CARBOXAMIDE

IUPAC name

1-{5-benzyl-4-oxo-4H5H6H7H8H-pyrazolo[15-a][14]diazepine-2-carbonyl}-N-[2-(dimethylamino)ethyl]piperidine-4-carboxamide

SMILES

CN(C)CCNC(C(CC1)CCN1C(c1nn(CCCN(Cc2ccccc2)C2=O)c2c1)=O)=O

InChI

InChI=1S/C25H34N6O3/c1-28(2)16-11-26-23(32)20-9-14-29(15-10-20)24(33)21-17-22-25(34)30(12-6-13-31(22)27-21)18-19-7-4-3-5-8-19/h3-5,7-8,17,20H,6,9-16,18H2,1-2H3,(H,26,32)

InChI Key

SHMIMMXHZJJFPD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19907346

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

466.58

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

0.589

Distribution Coefficient, logD

-1.040

Water Solubility, LogSw

-1.98

Polar Surface Area

75.422

Acid Dissociation Constant (pKa)

13.35

Base Dissociation Constant (pKb)

9.02

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.00

V025-1160 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Library (67538 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with V025-1160 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V025-1160?
Check Price and Availability of V025-1160, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V025-1160 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V025-1160
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V025-1160
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V025-1160 available by request